IL-1 Receptor Accessory Protein Inhibitors and Uses Thereof
Abstract:
The present disclosure provides novel antibodies and fragments thereof targeting IL-1RAcP (Interleukin-1 receptor accessory protein). Use of IL-1RAcP inhibitors are also provided herein.
Information query
Patent Agency Ranking
0/0